Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) Receives $20.80 Consensus Price Target from Analysts

Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT - Get Free Report) has been given a consensus rating of "Moderate Buy" by the five ratings firms that are currently covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $20.80.

Several analysts have issued reports on the stock. HC Wainwright reissued a "buy" rating and set a $33.00 target price on shares of Calumet Specialty Products Partners in a research note on Monday, March 3rd. Wells Fargo & Company decreased their target price on shares of Calumet Specialty Products Partners from $29.00 to $28.00 and set an "overweight" rating for the company in a research report on Wednesday, March 5th. TD Cowen lowered shares of Calumet Specialty Products Partners from a "buy" rating to a "hold" rating and reduced their price objective for the company from $26.00 to $16.00 in a research note on Tuesday, March 4th. Finally, UBS Group upgraded shares of Calumet Specialty Products Partners from a "sell" rating to a "neutral" rating and decreased their price objective for the stock from $15.00 to $12.00 in a report on Monday, March 17th.

Insider Buying and Selling

In other Calumet Specialty Products Partners news, Director Stephen P. Mawer sold 3,655 shares of the firm's stock in a transaction that occurred on Monday, March 24th. The stock was sold at an average price of $12.88, for a total value of $47,076.40. Following the sale, the director now owns 287,307 shares of the company's stock, valued at $3,700,514.16. This trade represents a 1.26 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CFO David Lunin purchased 2,500 shares of the business's stock in a transaction dated Tuesday, March 4th. The shares were acquired at an average price of $13.05 per share, with a total value of $32,625.00. Following the completion of the acquisition, the chief financial officer now owns 2,500 shares of the company's stock, valued at approximately $32,625. The trade was a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 2.91% of the company's stock.

Remove Ads

Calumet Specialty Products Partners Stock Down 2.2 %

CLMT traded down $0.29 during trading on Wednesday, reaching $13.16. The stock had a trading volume of 1,425,518 shares, compared to its average volume of 735,015. Calumet Specialty Products Partners has a 1-year low of $9.97 and a 1-year high of $25.29. The firm has a market capitalization of $1.13 billion, a price-to-earnings ratio of -4.77 and a beta of 1.88. The stock has a 50 day moving average of $14.72 and a two-hundred day moving average of $18.47.

Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) last announced its quarterly earnings data on Friday, February 28th. The oil and gas company reported ($0.47) earnings per share for the quarter, beating the consensus estimate of ($1.06) by $0.59. The firm had revenue of $949.50 million during the quarter, compared to analyst estimates of $921.76 million. During the same quarter last year, the company earned ($0.59) EPS. The company's quarterly revenue was down 2.8% compared to the same quarter last year. On average, research analysts forecast that Calumet Specialty Products Partners will post -3.02 EPS for the current fiscal year.

About Calumet Specialty Products Partners

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.